In most circumstances, well-controlled, hygienic water is delivered from water plants to cities. However within buildings, water can stagnate and its temperature increase. It passes through complex internal distribution systems consisting of narrow pipes with possibly corroded inner surfaces and dead ends. This environment can provide optimal conditions for the formation of biofilm from which bacteria and other microorganisms may be continuously released into the water.
Your Reliable Business Partner with a Proven Track Record in Technology Innovation, Manufacturing Excellence and Regulatory Compliance
Pall Corporation offers a comprehensive portfolio of advanced medical filtration devices and microporous membranes with robust performance characteristics and documented quality compliance.
Our technical experts will help you find the best Medical OEM Filters to satisfy your product requirements for Diagnostic and Healthcare Applications. Combining extensive membrane manufacturing capabilities with advanced medical engineering and design expertise, Pall can create unique and reliable solutions for your specific application needs. Our adherence to internationally recognized quality and six sigma principles assure consistent lot-to-lot performance and compliance with global industry standards.
Get to Know Our State-of-the-Art Intravenous (IV) In-Line Filtration Systems
Intravenous drug infusions are a life-saving therapy. But unfortunately, these drugs may be infused in conjunction with inadvertent ambient air, bacteria, endotoxins and particles which can potentially put the patient’s health at risk.1-4
A Decision as Easy as Breathing
In the medical industry the health and safety of patients and health care workers are everyone’s top priority.
Everyday millions of health care professionals dedicate their work to detect and cure disease while caring for their patients. Even if high levels of cleanliness have been established, patients and health care workers may be exposed to contamination causing infection in the hospital environment. Health and safety of both patients and health care workers are top priorities in our activities. We provide filtration technology which can help to control the contamination and infection risks associated with mechanical ventilation and other medical gases.
For over 40 years, hematopoietic stem cells from bone marrow have provided stem cell transplant options to facilitate treatment for leukemia and other blood disorders. More recently, peripheral blood has provided a less invasive source of stem cells. In 1988, the first transplant of stem cells from umbilical cord blood was used to successfully treat a child with Fanconi’s anemia, presenting yet another stem cell therapy option. Continued clinical research and advances in cord blood banking have now moved cord blood stem cells to the forefront of treatment for both pediatric and adult patients. We are committed to advancing technologies for this field.